These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 32430632)

  • 21. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
    Sandell J; Halldin C; Pike VW; Chou YH; Varnäs K; Hall H; Marchais S; Nowicki B; Wikström HV; Swahn CG; Farde L
    Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in vitro pharmacology of the beta-adrenergic receptor pet ligand (s)-fluorocarazolol reveals high affinity for cloned beta-adrenergic receptors and moderate affinity for the human 5-HT1A receptor.
    Roth BL; Ernsberger P; Steinberg SA; Rao S; Rauser L; Savage J; Hufeisen S; Berridge MS; Muzic RF
    Psychopharmacology (Berl); 2001 Aug; 157(1):111-4. PubMed ID: 11512051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of [O-methyl-3H]WAY-100635 as an in vivo radioligand for 5-HT1A receptors in rat brain.
    Hume SP; Ashworth S; Opacka-Juffry J; Ahier RG; Lammertsma AA; Pike VW; Cliffe IA; Fletcher A; White AC
    Eur J Pharmacol; 1994 Dec; 271(2-3):515-23. PubMed ID: 7705452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two C-methyl derivatives of [11C]WAY-100635--effects of an amido alpha-methyl group on metabolism and brain 5-HT1A receptor radioligand behavior in monkey.
    McCarron JA; Marchais-Oberwinkler S; Pike VW; Tarkiainen J; Halldin C; Sóvagó J; Gulyas B; Wikström HV; Farde L
    Mol Imaging Biol; 2005; 7(3):209-19. PubMed ID: 15912425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and in vivo validation of [O-methyl-11C]2-{4-[4-(7-methoxynaphthalen-1-yl)piperazin- 1-yl]butyl}-4-methyl-2H-[1,2,4]triazine-3,5-dione: a novel 5-HT1A receptor agonist positron emission tomography ligand.
    Kumar JS; Majo VJ; Hsiung SC; Millak MS; Liu KP; Tamir H; Prabhakaran J; Simpson NR; Van Heertum RL; Mann JJ; Parsey RV
    J Med Chem; 2006 Jan; 49(1):125-34. PubMed ID: 16392798
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syntheses and pharmacological evaluation of two potent antagonists for dopamine D4 receptors: [11C]YM-50001 and N-[2-[4-(4-Chlorophenyl)-piperizin-1-yl]ethyl]-3-[11C]methoxybenzamide.
    Zhang MR; Haradahira T; Maeda J; Okauchi T; Kawabe K; Noguchi J; Kida T; Suzuki K; Suhara T
    Nucl Med Biol; 2002 Feb; 29(2):233-41. PubMed ID: 11823129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of potent and selective antagonists at postsynaptic 5-HT1A receptors in a series of N4-substituted arylpiperazines.
    Peglion JL; Canton H; Bervoets K; Audinot V; Brocco M; Gobert A; Le Marouille-Girardon S; Millan MJ
    J Med Chem; 1995 Sep; 38(20):4044-55. PubMed ID: 7562940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PET radiotracers for molecular imaging of serotonin 5-HT1A receptors.
    Billard T; Le Bars D; Zimmer L
    Curr Med Chem; 2014; 21(1):70-81. PubMed ID: 23992341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of PET and the radioligand [carbonyl-(11)C]WAY-100635 in psychotropic drug development.
    Andrée B; Halldin C; Thorberg SO; Sandell J; Farde L
    Nucl Med Biol; 2000 Jul; 27(5):515-21. PubMed ID: 10962260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and Characterization of Carbon-11 Labeled Iloperidone for Imaging of α
    Xu Y; Wang Y; Wang H; Wang C
    Front Mol Biosci; 2020; 7():586327. PubMed ID: 33195432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of structural alterations on the radiopharmacological profile of
    Tietz O; Marshall A; Bergman C; Wuest M; Wuest F
    Nucl Med Biol; 2018; 62-63():9-17. PubMed ID: 29800798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New 5-hydroxytryptamine(1A) receptor ligands containing a norbornene nucleus: synthesis and in vitro pharmacological evaluation.
    Fiorino F; Perissutti E; Severino B; Santagada V; Cirillo D; Terracciano S; Massarelli P; Bruni G; Collavoli E; Renner C; Caliendo G
    J Med Chem; 2005 Aug; 48(17):5495-503. PubMed ID: 16107148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The PET radioligand [carbonyl-(11)C]desmethyl-WAY-100635 binds to 5-HT(1A) receptors and provides a higher radioactive signal than [carbonyl-(11)C]WAY-100635 in the human brain.
    Andrée B; Halldin C; Pike VW; Gunn RN; Olsson H; Farde L
    J Nucl Med; 2002 Mar; 43(3):292-303. PubMed ID: 11884487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new positron emission tomography imaging agent for the serotonin transporter: synthesis, pharmacological characterization, and kinetic analysis of [11C]2-[2-(dimethylaminomethyl)phenylthio]-5-fluoromethylphenylamine ([11C]AFM).
    Huang Y; Hwang DR; Bae SA; Sudo Y; Guo N; Zhu Z; Narendran R; Laruelle M
    Nucl Med Biol; 2004 Jul; 31(5):543-56. PubMed ID: 15219271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [
    Colom M; Vidal B; Fieux S; Redoute J; Costes N; Lavenne F; Mérida I; Irace Z; Iecker T; Bouillot C; Billard T; Newman-Tancredi A; Zimmer L
    Front Neurosci; 2021; 15():622423. PubMed ID: 33762906
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Marmoset Serotonin 5-HT1A Receptor Mapping with a Biased Agonist PET Probe 18F-F13714: Comparison with an Antagonist Tracer 18F-MPPF in Awake and Anesthetized States.
    Yokoyama C; Mawatari A; Kawasaki A; Takeda C; Onoe K; Doi H; Newman-Tancredi A; Zimmer L; Onoe H
    Int J Neuropsychopharmacol; 2016 Dec; 19(12):. PubMed ID: 27608810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biologic evaluation of a novel serotonin 5-HT1A receptor radioligand, 18F-labeled mefway, in rodents and imaging by PET in a nonhuman primate.
    Saigal N; Pichika R; Easwaramoorthy B; Collins D; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
    J Nucl Med; 2006 Oct; 47(10):1697-706. PubMed ID: 17015907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.
    Ettrup A; Palner M; Gillings N; Santini MA; Hansen M; Kornum BR; Rasmussen LK; Någren K; Madsen J; Begtrup M; Knudsen GM
    J Nucl Med; 2010 Nov; 51(11):1763-70. PubMed ID: 20956470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, biological and autoradiographic evaluation of a novel Tc-99m radioligand derived from WAY 100635 with high affinity for the 5-HT(1A) receptor and the alpha1-adrenergic receptor.
    Heimbold I; Drews A; Kretzschmar M; Varnäs K; Hall H; Halldin C; Syhre R; Kraus W; Pietzsch HJ; Seifert S; Brust P; Johannsen B
    Nucl Med Biol; 2002 May; 29(4):375-87. PubMed ID: 12031872
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.